Lithium sulphate prolonged-release 660 mg for bipolar disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Mar 2017: Trial started, NCT03210480
  2. 7 Jul 2017: Trial registered, NCT03210480
  3. 20 Sep 2019: Trial terminated, NCT03210480

The trials

NCT03210480: SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)

State
Stopped early
Phase
Phase 4
People
85 taking part
Started
28 Mar 2017
Primary completion
20 Sep 2019
Arms
Group 1
Results
None posted
  1. 28 Mar 2017: Trial started
  2. 7 Jul 2017: Trial registered
  3. 20 Sep 2019: Trial terminated

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.